Portfolio (Quarterly)
Guide ↗
Virtus Investment Advisers, LLC
· CIK 0000019481| # | Ticker | Company | Sector | Shares | Value ↓ | % Port | Chg Shares | Chg % | Period Price ① | Since Period ① |
|---|---|---|---|---|---|---|---|---|---|---|
| 81 | BNTX | BIONTECH SE | Healthcare | 12,844.0 | $1.2M | 0.28% | +4K | +44.2% | $93.05 | -1.6% |
| 82 | HRZN | HORIZON TECHNOLOGY FIN CORP | Financial Services | 252,455.0 | $1.2M | 0.28% | +108K | +75.3% | $4.73 | +5.7% |
| 83 | EXEL | EXELIXIS INC | Healthcare | 21,887.0 | $1.2M | 0.28% | +1K | +6.0% | $54.41 | -3.8% |
| 84 | BMRN | BIOMARIN PHARMACEUTICAL INC | Healthcare | 20,784.0 | $1.2M | 0.28% | +5K | +31.2% | $57.22 | +16.5% |
| 85 | TBPH | THERAVANCE BIOPHARMA INC | Healthcare | 69,885.0 | $1.2M | 0.28% | +23K | +50.4% | $17.00 | -0.5% |
| 86 | ADMA | ADMA BIOLOGICS INC | Healthcare | 141,642.0 | $1.2M | 0.28% | +99K | +231.8% | $8.37 | +11.6% |
| 87 | TARS | TARSUS PHARMACEUTICALS INC | Healthcare | 18,771.0 | $1.2M | 0.28% | +8K | +80.9% | $62.94 | +12.2% |
| 88 | UTHR | UNITED THERAPEUTICS CORP DEL | Healthcare | 2,130.0 | $1.2M | 0.27% | +423.0 | +24.8% | $541.83 | -6.2% |
| 89 | — | VERASTEM INC | — | 283,630.0 | $1.1M | 0.25% | +255K | +899.6% | $3.82 | — |
| 90 | ARDX | ARDELYX INC | Healthcare | 204,373.0 | $1.0M | 0.24% | +68K | +50.3% | $5.10 | -20.4% |
| 91 | PSEC | PROSPECT CAP CORP | Financial Services | 428,612.0 | $990K | 0.23% | +91K | +26.8% | $2.31 | -4.3% |
| 92 | TCPC | BLACKROCK TCP CAPITAL CORP | Financial Services | 258,829.0 | $870K | 0.20% | +12K | +4.7% | $3.36 | +21.4% |
| 93 | FSK | FS KKR CAP CORP | Financial Services | 74,745.0 | $785K | 0.18% | +3K | +3.5% | $10.50 | +14.4% |
| 94 | PNNT | PENNANTPARK INVT CORP | Financial Services | 216,246.0 | $750K | 0.17% | +51K | +30.6% | $3.47 | +4.6% |
| 95 | RWAY | RUNWAY GROWTH FINANCE CORP | Financial Services | 121,023.0 | $679K | 0.16% | +24K | +25.0% | $5.61 | +15.0% |
| 96 | CION | CION INVT CORP | Financial Services | 108,061.0 | $673K | 0.16% | +19K | +20.9% | $6.23 | +15.7% |
| 97 | RGNX | REGENXBIO INC | Healthcare | 49,129.0 | $589K | 0.14% | +29K | +149.9% | $11.98 | -5.4% |
| 98 | SCM | STELLUS CAP INVT CORP | Financial Services | 62,135.0 | $523K | 0.12% | +1K | +2.4% | $8.42 | +1.9% |
| 99 | CCAP | CRESCENT CAP BDC INC | Financial Services | 47,621.0 | $520K | 0.12% | +3K | +6.0% | $10.92 | -0.9% |
| 100 | MBX | MBX BIOSCIENCES INC | Healthcare | 9,215.0 | $509K | 0.12% | +84.0 | +0.9% | $55.20 | +23.6% |
① Period Price is the implied market price on the last day of the reporting period, calculated as reported value ÷ shares held. It is not the fund's purchase price or cost basis — the fund may have initiated or added to the position at any point during the quarter at a different price. Since Period shows the price change from that quarter-end snapshot to today's last price — it reflects stock movement after the report date, not the fund's actual return.
Sector Allocation
Healthcare
36.7%
Technology
15.7%
Financial Services
15.3%
Industrials
13.0%
Consumer Cyclical
5.8%
Energy
4.7%
Real Estate
2.8%
Utilities
1.7%
Communication Services
1.7%
Basic Materials
1.5%